Case 2 (cont.)—Metastatic NSCLC With a ROS1 Alteration: Patients With CNS Disease
March 26th 2025Panelists discuss the management of metastatic non–-small cell lung cancer (NSCLC) with a ROS1 alteration in patients with central nervous system (CNS) involvement, focusing on treatment strategies and challenges.
Case Presentation: Second-Line Decision- Making for KRAS-Mutated Metastatic NSCLC
February 26th 2025Panelists discuss second-line treatment decision-making for KRAS-mutated metastatic non–-small cell lung cancer (NSCLC), focusing on available therapies and personalized approaches based on patient characteristics.
Case 1 Presentation—KRAS-Mutated Metastatic NSCLC: First-Line Decision- Making
February 19th 2025Panelists discuss first-line treatment decision-making for KRAS-mutated metastatic non–-small cell lung cancer (NSCLC), focusing on the selection of targeted therapies and factors influencing clinical choices.